Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer

Autor: Hansma, A.H.G. ^*, Broxterman, H.J., van der Horst, I., Yuana, Y., Boven, E., Giaccone, G., Pinedo, H.M., Hoekman, K.

Publikováno v: In Annals of Oncology October 2005 16(10):1695-1701

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature

Autor: Gotink, K.J., Broxterman, H.J., Honeywell, R.J., Dekker, H., de Haas, R.R., Miles, K.M., Adelaiye, R., Griffioen, A.W., Peters, G.J., Pili, R., Verheul, H.M.W.

Publikováno v: Gotink, K J, Broxterman, H J, Honeywell, R J, Dekker, H, de Haas, R R, Miles, K M, Adelaiye, R, Griffioen, A W, Peters, G J, Pili, R & Verheul, H M W 2014, ' Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature ', Oncoscience, vol. 1, no. 12, pp. 844-853 . < http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303892/ >
Oncoscience, 1(12), 844-853. Impact Journals

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7b70409f71d8ff91357d8c7bc9eb9fc4
https://research.vumc.nl/en/publications/3b5c2615-58c3-43db-a2a0-38a39143a61e

Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia

Autor: van der Pol, M.A., Broxterman, H.J., Pater, JM, Feller, N., Maas, M., Weijers, GW, Scheffer, G.L., Allen, JD, Scheper, R.J., van Loevezijn, A, Ossenkoppele, G.J., Schuurhuis, G.J.

Publikováno v: Haematologica, 88(2), 134-47. Ferrata Storti Foundation
van der Pol, M A, Broxterman, H J, Pater, JM, Feller, N, Maas, M, Weijers, GW, Scheffer, G L, Allen, JD, Scheper, R J, van Loevezijn, A, Ossenkoppele, G J & Schuurhuis, G J 2003, ' Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia. ', Haematologica, vol. 88, no. 2, pp. 134-47 . < http://haematologica-thj.org/cgi/reprint/88/2/134.pdf >

BACKGROUND AND OBJECTIVES: Relapse is common in acute myeloid leukemia (AML) because of persistence of minimal residual disease (MRD). ABC-transporters P-glycoprotein (Pgp) and multidrug resistance protein (MRP), are thought to contribute to treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c301ca6fa58407f532993ada7d9f40b3
https://research.vu.nl/en/publications/796ca827-4052-42b6-b065-16e1da14b516

Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells

Autor: van der Pol, M.A., Feller, N., Roseboom, M, Moshaver, B, Westra, G, Broxterman, H.J., Ossenkoppele, G.J., Schuurhuis, G.J.

Publikováno v: Haematologica, 88(9), 983-93. Ferrata Storti Foundation
van der Pol, M A, Feller, N, Roseboom, M, Moshaver, B, Westra, G, Broxterman, H J, Ossenkoppele, G J & Schuurhuis, G J 2003, ' Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells. ', Haematologica, vol. 88, no. 9, pp. 983-93 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::92c701ad60921cd39b7b692b0dbe1976
https://research.vumc.nl/en/publications/df8f5864-fa99-4ad5-9194-8291a430ba7c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.